| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |